US Patent 7105490 Methods and compositions for treating polycystic ovary syndrome
Patent 7105490 was granted and assigned to Amylin Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrew A. Young1
David R. Hathaway1
Kathryn S. Prickett1
Nigel Robert Arnold Beeley1
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+234 characters)
Article
Patent abstract
The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1), exendin, and analogs and agonists thereof, to subjects suffering therefrom.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07105490 Methods and compositions for treating polycystic ovary syndrome US Patent 7105490 Methods and compositions for treating polycystic ovary syndrome
Infobox
Patent Number
071054901
Patent Number
71054901
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071054901
Date of Patent
September 12, 2006
1Patent Application Number
106296491
Date Filed
July 30, 2003
1Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07105490 Methods and compositions for treating polycystic ovary syndrome
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07105490
Date of patent
September 12, 2006
Patent application number
10629649
Date Filed
July 30, 2003
Patent primary examiner
Find more entities like US Patent 7105490 Methods and compositions for treating polycystic ovary syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
